Carbapenem resistant Acinetobacter baumannii is becoming increasingly prevalent in 22 patients with diabetes mellitus in the Middle East. We examined the relationship between 23 these bacteria and their resistance mechanisms with the diabetic disease status of patients. 24 Susceptibilities of 271 isolates to carbapenems, tigecycline and colistin were determined, 25 followed by detection of carbapenemase genes. A bla VIM gene was detected in ~95% isolates; 26 bla OXA-23 and bla OXA-40 genes were also prevalent. Diabetic patients were significantly more 27 likely to carry carbapenem-resistant isolates. Carbapenem resistant A. baumannii is a serious 28 problem in diabetics, and molecular detection of resistance mechanisms in these isolates is 29 required. 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 48 bacteria, Acinetobacter baumannii, has risen to prominence due to the international 49 dissemination of multidrug-resistant lineages resistant to the carbapenem antibiotics (Higgins 50 et al., 2009; Towner et al., 2008; Turton et al., 2007). A. baumannii can become resistant to 51 the carbapenems through a number of mechanisms including expression of OXA-type 52 carbapenemases and expression of an acquired metallo-β-lactamase (Evans et al., 2013; 53 Turton et al., 2006). Recent studies have shown that the prevalence of carbapenem-resistant 54 A. baumannii can be incredibly high in the Middle East (Al Johani et al., 2010; Mugnier et 55 al., 2009).
Introduction
One of the greatest threats to modern medicine is the increasing prevalence of antibioticresistant bacteria, particularly Gram-negative bacteria (Boucher et al., 2009) 
